Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Actuate Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)